ドライアイ症候群治療の市場規模・シェア・動向分析レポート：タイプ別、薬剤別、製品別、剤形別、販売チャネル別、流通チャネル別、地域別,セグメント動向：2024年～2030年

ドライアイ症候群治療市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のドライアイ症候群治療市場規模は、2024年から2030年にかけてCAGR 7.97％を記録し、2030年には101億3,000万米ドルに達すると予測されています。

同市場の成長は、スクリーン使用の増加、老人人口の増加、眼疾患の有病率の上昇などの要因によるものです。

スクリーン付きデバイスの使用の増加、コンピュータの使用の急増、まばたきの回数の減少などが、蒸発性ドライアイ症候群の世界の成長をもたらしています。例えば、2021年のFrontiers Journalによると、パンデミック前と比較した場合、COVID-19パンデミックの間、スクリーンの使用は成人で60～80％増加しました。スクリーンにさらされるとまばたきの回数が66％減少するため、涙の蒸発が促進され、ドライアイにつながります。

医療用医薬品の受容率が極めて低いため、マーケットプレースでは一般用医薬品（OTC）が主流となっています。例えば、ドライアイと診断された患者のうち、処方箋による治療を受けているのは10%に過ぎず、75%の患者は処方箋による治療を試したことがないです。しかし、ドライアイ症候群と診断された患者数は、眼科医による診察全体の5～35％を占めています。

さらに、ザイドラやレスタシスのような既存製品は、効果が現れるまでに数ヶ月から数週間かかります。さらに、眼科医によると、これらの製品には忍容性の問題があり、失敗率は50％にも上るといいます。このため、市場にはアンメット・ニーズが存在し、今後数年間に発売されるパイプライン製品に有利な機会が生まれると予想されています。さらに、医薬品に関連する規制が市場全体の成長を妨げています。例えば、2020年、ノバルティスは、規制当局がキシドラの使用に大きな異議を唱えたため、欧州でのキシドラの使用を自主的に撤回せざるを得なくなった。

主要企業によるイノベーションと戦略的取り組みが市場を牽引しています。新製品の上市は、各社が採用している一般的な戦略です。例えば、2021年10月、Oyster Point Pharma社のTyrvaya（バレニクリン溶液）点鼻スプレーが代替治療アプローチとしてFDAに承認されました。

ドライアイ症候群治療市場レポートハイライト

• タイプ別では、蒸発性ドライアイ症候群が2023年に最大シェアを占めました。
• 剤形別では、入手のしやすさと点眼投与への嗜好の高まりにより、点眼薬が2023年に最大の売上シェアを占めました。
• 薬剤別では、ドライアイ治療の処方薬として高い採用率を誇るレスタシスが2023年に最大の市場シェアを占めました。
• 販売チャネル別では、利便性の高さからオンライン薬局に対する消費者の嗜好が高まっていることから、オンライン薬局が予測期間中に最も速い速度で成長すると予想されます。
• ドライアイの有病率の高さ、認知度の急上昇、治療率の向上により、2023年の市場は北米が支配的でした。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場の系譜
  • 親市場分析
  • 補助市場分析
• ドライアイ症候群治療市場-市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• ビジネス環境ツール分析：ドライアイ症候群治療市場
  • ポーターのファイブフォース分析
  • PESTLE分析
• パイプライン分析
• 価格分析

第4章 ドライアイ症候群治療市場：タイプの推定・動向分析

• ドライアイ症候群治療市場：タイプダッシュボード
• ドライアイ症候群治療市場：タイプ変動分析
• タイプ別市場推計・予測、2018年-2030年
• 蒸発性ドライアイ症候群
• 涙液減少性ドライアイ症候群

第5章 ドライアイ症候群治療市場：薬剤の推定・動向分析

• ドライアイ症候群治療市場：薬剤ダッシュボード
• ドライアイ症候群治療市場：薬剤変動分析
• 薬物別市場推計・予測、2018年-2030年
• レスタシス
• シイドラ
• セクア
• エイスヴィス
• ティルヴァヤ
• その他

第6章 ドライアイ症候群治療市場：製品の推定・動向分析

• ドライアイ症候群治療市場：製品ダッシュボード
• ドライアイ症候群治療市場：製品変動分析
• 製品別市場推計・予測、2018年-2030年
• シクロスポリン
• 局所コルチコステロイド
• 人工涙液
• 涙点プラグ
• 経口オメガサプリメント
• その他

第7章 ドライアイ症候群治療市場：剤形の推定・動向分析

• ドライアイ症候群治療市場：剤形ダッシュボード
• ドライアイ症候群治療市場：剤形変動分析
• 剤形別市場推計・予測、2018年-2030年
• ジェル
• アイソリューション
• カプセルとタブレット
• 目薬
• 軟膏

第8章 ドライアイ症候群治療市場：販売チャネルの推定・動向分析

• ドライアイ症候群治療市場：販売チャネルダッシュボード
• ドライアイ症候群治療市場：販売チャネル変動分析
• 販売チャネル別市場推計・予測、2018年-2030年
• 処方箋
• 店頭

第9章 ドライアイ症候群治療市場：流通チャネルの推定・動向分析

• ドライアイ症候群治療市場：流通チャネルダッシュボード
• ドライアイ症候群治療市場：流通チャネル変動分析
• 流通チャネル別市場推計・予測、2018年-2030年
• 病院薬局
• オンライン薬局
• 小売薬局

第10章 ドライアイ症候群治療市場：地域の推定・動向分析

• ドライアイ症候群治療市場：地域変動分析、2022年および2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • タイ
  • 韓国
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第11章 競合情勢

• 企業分類
• 企業市場シェア分析、2022年
• 戦略マッピング
• 企業プロファイル/上場企業
  • NOVARTIS AG.
  • ABBVIE, INC.
  • SUN PHARMACEUTICAL INDUSTRIES LTD.
  • SANTEN PHARMACEUTICAL CO., LTD.
  • AFT PHARMACEUTICALS
  • JOHNSON &JOHNSON SERVICES, INC.
  • OTSUKA PHARMACEUTICAL CO., LTD.
  • OASIS MEDICAL.
  • OYSTER POINT PHARMA, INC.
  • BAUSCH &LOMB

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviation
• Table 3 Incidence of Diseases
• Table 4 Global Dry Eye Syndrome Treatment Market, By Region, 2018 - 2030 (USD Million)
• Table 5 Global Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 6 Global Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 7 Global Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 8 Global Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 9 Global Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 10 Global Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 11 North America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 12 North America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 13 North America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 14 North America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 15 North America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 16 North America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 17 North America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 18 U.S. Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 19 U.S. Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 20 U.S. Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 21 U.S. Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 22 U.S. Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 23 U.S. Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 24 Canada Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 25 Canada Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 26 Canada Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 27 Canada Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 28 Canada Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 29 Canada Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 30 Europe Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 31 Europe Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 32 Europe Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 33 Europe Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 34 Europe Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 35 Europe Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 36 Europe Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 37 Germany Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 38 Germany Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 39 Germany Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 40 Germany Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 41 Germany Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 42 Germany Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 43 UK Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 44 UK Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 45 UK Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 46 UK Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 47 UK Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 48 UK Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 49 France Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 50 France Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 51 France Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 52 France Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 53 France Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 54 France Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 55 Italy Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 56 Italy Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 57 Italy Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 58 Italy Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 59 Italy Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 60 Italy Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 61 Spain Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 62 Spain Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 63 Spain Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 64 Spain Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 65 Spain Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 66 Spain Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 67 Asia Pacific Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 68 Asia Pacific Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 69 Asia Pacific Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 70 Asia pacific Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 71 Asia Pacific Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 72 Asia Pacific Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 73 Asia Pacific Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 74 Japan Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 75 Japan Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 76 Japan Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 77 Japan Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 78 Japan Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 79 Japan Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 80 China Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 81 China Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 82 China Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 83 China Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 84 China Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 85 China Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 86 India Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 87 India Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 88 India Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 89 India Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 90 India Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 91 India Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 92 South Korea Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 93 South Korea Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 94 South Korea Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 95 South Korea Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 96 South Korea Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 97 South Korea Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 98 Australia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 99 Australia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 100 Australia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 101 Australia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 102 Australia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 103 Australia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 104 Latin America Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 105 Latin America Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 106 Latin America Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 107 Latin America Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 108 Latin America Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 109 Latin America Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 110 Latin America Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 111 Brazil Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 112 Brazil Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 113 Brazil Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 114 Brazil Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 115 Brazil Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 116 Brazil Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 117 Mexico Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 118 Mexico Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 119 Mexico Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 120 Mexico Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 121 Mexico Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 122 Mexico Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 123 Argentina Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 124 Argentina Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 125 Argentina Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 126 Argentina Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 127 Argentina Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 128 Argentina Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 129 Middle East & Africa Dry Eye Syndrome Treatment Market, By Country, 2018 - 2030 (USD Million)
• Table 130 Middle East & Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 131 Middle East & Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 132 Middle East & Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 133 Middle East & Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 134 Middle East & Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 135 Middle East & Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 136 Saudi Arabia Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 137 Saudi Arabia Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 138 Saudi Arabia Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 139 Saudi Arabia Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 140 Saudi Arabia Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 141 Saudi Arabia Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 142 South Africa Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 143 South Africa Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 144 South Africa Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 145 South Africa Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 146 South Africa Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 147 South Africa Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)
• Table 148 UAE Dry Eye Syndrome Treatment Market, By Type, 2018 - 2030 (USD Million)
• Table 149 UAE Dry Eye Syndrome Treatment Market, By Product, 2018 - 2030 (USD Million)
• Table 150 UAE Dry Eye Syndrome Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
• Table 151 UAE Dry Eye Syndrome Treatment Market, By Dosage Form, 2018 - 2030 (USD Million)
• Table 152 UAE Dry Eye Syndrome Treatment Market, By Drug, 2018 - 2030 (USD Million)
• Table 153 UAE Dry Eye Syndrome Treatment Market, By Sales Channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Dry eye syndrome treatment market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Dry eye syndrome treatment market snapshot
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook, revenue, 2023, (USD Million)
• Fig. 12 Penetration and growth prospect mapping
• Fig. 13 Dry eye syndrome treatment market driver impact
• Fig. 14 Dry eye syndrome treatment market restraint impact
• Fig. 15 SWOT analysis, by factor (political & legal, economic, and technological)
• Fig. 16 Industry Analysis - Porter's
• Fig. 17 Strategy mapping
• Fig. 18 Dry eye syndrome treatment market: type outlook and key takeaways
• Fig. 19 Dry eye syndrome treatment market: type movement analysis & market share 2023 & 2030
• Fig. 20 Evaporative dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Aqueous dry eye syndrome treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Dry eye syndrome treatment market: product outlook and key takeaways
• Fig. 23 Dry eye syndrome treatment market: product movement analysis & market share 2023 & 2030
• Fig. 24 Gels market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Capsules and tablets market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Eye solutions market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Ointments market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Dry eye syndrome treatment market: distribution channel outlook and key takeaways
• Fig. 30 Dry eye syndrome treatment market: distribution channel movement analysis & market share 2022 & 2030
• Fig. 31 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 32 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Online pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Dry eye syndrome treatment market: Prescription outlook and key takeaways
• Fig. 35 Dry eye syndrome treatment market: Prescription channel movement analysis & market share 2022 & 2030
• Fig. 36 Prescription market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 37 OTC market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 38 Dry eye syndrome treatment market: Product outlook and key takeaways
• Fig. 39 Dry eye syndrome treatment market: Product channel movement analysis & market share 2022 & 2030
• Fig. 40 Cyclosporine market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 41 Topical Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 42 Artificial Tears market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 43 Punctal Plugs market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 44 Removable market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 45 Dissolvable market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 46 Oral Omega Supplements market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 47 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 48 Dry eye syndrome treatment market: Drug outlook and key takeaways
• Fig. 49 Dry eye syndrome treatment market: Drug channel movement analysis & market share 2022 & 2030
• Fig. 50 Restasis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 51 Xiidra market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 52 Cequa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 53 Eysuvis market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 54 Tyrvaya market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 55 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 56 Dry Eye Syndrome Treatment: Regional outlook and key takeaways
• Fig. 57 Regional outlook, 2023 & 2030
• Fig. 58 North America
• Fig. 59 North America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 60 U.S.
• Fig. 61 U.S. market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 62 Canada
• Fig. 63 Canada market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 64 Mexico
• Fig. 65 Mexico market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 66 Europe
• Fig. 67 Europe market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 68 UK
• Fig. 69 UK market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 70 Germany
• Fig. 71 Germany market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 72 France
• Fig. 73 France market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 74 Italy
• Fig. 75 Italy market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 76 Spain
• Fig. 77 Spain market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 78 Asia-Pacific
• Fig. 79 Asia-Pacific market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 80 Japan
• Fig. 81 Japan market estimates and forecast, 2018 - 2030(USD Million)
• Fig. 82 China
• Fig. 83 China market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 84 India
• Fig. 85 India market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 86 South Korea
• Fig. 87 South Korea market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 88 Australia
• Fig. 89 Australia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 90 Latin America
• Fig. 91 Latin America market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 92 Brazil
• Fig. 93 Brazil market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 94 Argentina
• Fig. 95 Argentina market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 96 Middle East & Africa
• Fig. 97 MEA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 98 South Africa
• Fig. 99 South Africa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 100 Saudi Arabia
• Fig. 101 Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 102 UAE
• Fig. 103 UAE market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 104 Ansoff Matrix
• Fig. 105 Market differentiators
• Fig. 106 Key company market share analysis, 2023
• Fig. 107 Company market position analysis
• Fig. 108 Competitive dashboard analysis
• Fig. 109 Regional network map

Dry Eye Syndrome Treatment Market Growth & Trends:

The global dry eye syndrome treatment market size is expected to reach USD 10.13 billion by 2030, registering a CAGR of 7.97% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors such as the increasing use of screens, the rising geriatric population, and a heightened prevalence of eye diseases.

The heightened use of devices with a screen, surging use of computers, and a decreased number of blinks are subsequently leading to the growth of evaporative dry eye syndrome globally. For instance, as per Frontiers Journal in 2021, when compared to pre-pandemic years, the use of screens has increased by 60-80% in adults during the COVID-19 pandemic. The exposure to the screen leads to a 66% decreased blinking rate, thus escalating the evaporation of tears and leading to dry eye disease.

Over-the-counter (OTC) products predominate the marketplace due to the extremely low acceptance of prescription products. For instance, only 10% of the diagnosed population is on prescription therapies, while 75% of the population has never tried prescription therapy. However, the number of patients diagnosed with dry eye syndrome accounts for 5-35% of overall ophthalmologist visits.

Moreover, existing products such as Xiidra and Restasis take months or weeks to demonstrate effects. In addition, as per eye consultants, these products have tolerability issues and a failure rate of as high as 50%. This depicts an unmet need in the market and is anticipated to create a lucrative opportunity for pipeline products expected to launch in the upcoming years. Moreover, regulations associated with the drugs further hamper the growth of the overall market. For instance, in 2020, Novartis had to voluntarily withdraw the use of Xiidra in Europe after regulators raised major objections to its use of xiidra.

Innovations and strategic initiatives by key players are driving the market. New product launch is a common strategy being used by the players. For instance, in October 2021, Tyrvaya (varenicline solution) nasal spray by Oyster Point Pharma was approved by the FDA as an alternative treatment approach.

Dry Eye Syndrome Treatment Market Report Highlights:

• By type, evaporative dry eye syndrome held the largest share in 2023 owing to the increasing prevalence of the condition and heightened screen time
• Based on dosage form, eye drops held the largest revenue share in 2023 owing to easy availability as well as increased preference for eye drop administration of the product
• By drug, Restasis held the largest market share in 2023 owing to its high adoption as a prescription drug for dry eye treatment
• Based on distribution channel, online pharmacies are expected to grow at the fastest rate over the forecast period due to the increased consumer preference for online pharmacies owing to the convenience
• North America dominated the market in 2023 due to the high prevalence of the disease, surging awareness, and enhanced treatment rate

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Disease
  • 1.2.2. Treatment
  • 1.2.3. Regional Scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Disease outlook
  • 2.2.2. Treatment outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Market Variables, Trends, and Scope

• 3.1. Market Lineage
  • 3.1.1. Parent Market Analysis
  • 3.1.2. Ancillary Market Analysis
• 3.2. Dry Eye Syndrome Treatment Market - Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing geriatric population
    • 3.2.1.2. Increasing Prevalence of Dry Eye Syndrome
    • 3.2.1.3. Robust product pipeline
    • 3.2.1.4. Growing disease awareness and increasing use of contact lenses
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Competition from generic products
    • 3.2.2.2. High cost of treatments and lack of awareness among the general population in low- and middle-income countries
• 3.3. Business Environmental Tools Analysis: Dry Eye Syndrome Treatment Market
  • 3.3.1. Porter's Five Forces Analysis
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTLE Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape
• 3.4. Pipeline Analysis
• 3.5. Pricing Analysis

Chapter 4. Dry Eye Syndrome Treatment Market: Type Estimates & Trend Analysis

• 4.1. Dry Eye Syndrome Treatment Market: Type Dashboard
• 4.2. Dry Eye Syndrome Treatment Market: Type Movement Analysis
• 4.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Type, 2018 - 2030 (USD Million)
• 4.4. Evaporative Dry Eye Syndrome
  • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Aqueous Deficient Dry Eye Syndrome
  • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Dry Eye Syndrome Treatment Market: Drug Estimates & Trend Analysis

• 5.1. Dry Eye Syndrome Treatment Market: Drug Dashboard
• 5.2. Dry Eye Syndrome Treatment Market: Drug Movement Analysis
• 5.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Drug, 2018 - 2030 (USD Million)
• 5.4. Restasis
  • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Xiidra
  • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Cequa
  • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Eysuvis
  • 5.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Tyrvaya
  • 5.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Dry Eye Syndrome Treatment Market: Product Estimates & Trend Analysis

• 6.1. Dry Eye Syndrome Treatment Market: Product Dashboard
• 6.2. Dry Eye Syndrome Treatment Market: Product Movement Analysis
• 6.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Product, 2018 - 2030 (USD Million)
• 6.4. Cyclosporine
  • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Topical Corticosteroids
  • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Artificial Tears
  • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Punctal Plugs
  • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.2. Removable Punctal Plugs
    • 6.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7.3. Dissolvable Punctal Plugs
    • 6.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.8. Oral Omega Supplements
  • 6.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 6.9. Others
  • 6.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Dry Eye Syndrome Treatment Market: Dosage Form Estimates & Trend Analysis

• 7.1. Dry Eye Syndrome Treatment Market: Dosage Form Dashboard
• 7.2. Dry Eye Syndrome Treatment Market: Dosage Form Movement Analysis
• 7.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Dosage Form, 2018 - 2030 (USD Million)
• 7.4. Gels
  • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Eye Solutions
  • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Capsules & Tablets
  • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. Eye Drops
  • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 7.8. Ointments
  • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Dry Eye Syndrome Treatment Market: Sales Channel Estimates & Trend Analysis

• 8.1. Dry Eye Syndrome Treatment Market: Sales Channel Dashboard
• 8.2. Dry Eye Syndrome Treatment Market: Sales Channel Movement Analysis
• 8.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Sales Channel, 2018 - 2030 (USD Million)
• 8.4. Prescription
  • 8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. OTC
  • 8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Dry Eye Syndrome Treatment Market: Distribution Channel Estimates & Trend Analysis

• 9.1. Dry Eye Syndrome Treatment Market: Distribution Channel Dashboard
• 9.2. Dry Eye Syndrome Treatment Market: Distribution Channel Movement Analysis
• 9.3. Dry Eye Syndrome Treatment Market Estimates and Forecasts, By Distribution Channel, 2018 - 2030 (USD Million)
• 9.4. Hospital Pharmacies
  • 9.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 9.5. Online Pharmacies
  • 9.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
• 9.6. Retail Pharmacies
  • 9.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Dry Eye Syndrome Treatment Market: Regional Estimates & Trend Analysis

• 10.1. Dry Eye Syndrome Treatment Market: Regional Movement Analysis, 2022 & 2030
• 10.2. North America
  • 10.2.1. North America Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.2.2. U.S.
    • 10.2.2.1. Key Country Dynamics
    • 10.2.2.2. Competitive Scenario
    • 10.2.2.3. Prevalence Insights
    • 10.2.2.4. Regulatory Framework
    • 10.2.2.5. Reimbursement Structure
    • 10.2.2.6. U.S. Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.2.3. Canada
    • 10.2.3.1. Key Country Dynamics
    • 10.2.3.2. Competitive Scenario
    • 10.2.3.3. Prevalence Insights
    • 10.2.3.4. Regulatory Framework
    • 10.2.3.5. Reimbursement Structure
    • 10.2.3.6. Canada Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
• 10.3. Europe
  • 10.3.1. Europe Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.2. UK
    • 10.3.2.1. Key Country Dynamics
    • 10.3.2.2. Competitive Scenario
    • 10.3.2.3. Prevalence Insights
    • 10.3.2.4. Regulatory Framework
    • 10.3.2.5. Reimbursement Structure
    • 10.3.2.6. UK Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.3. Germany
    • 10.3.3.1. Key Country Dynamics
    • 10.3.3.2. Competitive Scenario
    • 10.3.3.3. Prevalence Insights
    • 10.3.3.4. Regulatory Framework
    • 10.3.3.5. Reimbursement Structure
    • 10.3.3.6. Germany Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.4. France
    • 10.3.4.1. Key Country Dynamics
    • 10.3.4.2. Competitive Scenario
    • 10.3.4.3. Prevalence Insights
    • 10.3.4.4. Regulatory Framework
    • 10.3.4.5. Reimbursement Structure
    • 10.3.4.6. France Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.5. Italy
    • 10.3.5.1. Key Country Dynamics
    • 10.3.5.2. Competitive Scenario
    • 10.3.5.3. Prevalence Insights
    • 10.3.5.4. Regulatory Framework
    • 10.3.5.5. Reimbursement Structure
    • 10.3.5.6. Italy Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.6. Spain
    • 10.3.6.1. Key Country Dynamics
    • 10.3.6.2. Competitive Scenario
    • 10.3.6.3. Prevalence Insights
    • 10.3.6.4. Regulatory Framework
    • 10.3.6.5. Reimbursement Structure
    • 10.3.6.6. Spain Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.7. Denmark
    • 10.3.7.1. Key Country Dynamics
    • 10.3.7.2. Competitive Scenario
    • 10.3.7.3. Prevalence Insights
    • 10.3.7.4. Regulatory Framework
    • 10.3.7.5. Reimbursement Structure
    • 10.3.7.6. Denmark Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.8. Sweden
    • 10.3.8.1. Key Country Dynamics
    • 10.3.8.2. Competitive Scenario
    • 10.3.8.3. Prevalence Insights
    • 10.3.8.4. Regulatory Framework
    • 10.3.8.5. Reimbursement Structure
    • 10.3.8.6. Sweden Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.3.9. Norway
    • 10.3.9.1. Key Country Dynamics
    • 10.3.9.2. Competitive Scenario
    • 10.3.9.3. Prevalence Insights
    • 10.3.9.4. Regulatory Framework
    • 10.3.9.5. Reimbursement Structure
    • 10.3.9.6. Norway Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
• 10.4. Asia Pacific
  • 10.4.1. Asia Pacific Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4.2. Japan
    • 10.4.2.1. Key Country Dynamics
    • 10.4.2.2. Competitive Scenario
    • 10.4.2.3. Prevalence Insights
    • 10.4.2.4. Regulatory Framework
    • 10.4.2.5. Reimbursement Structure
    • 10.4.2.6. Japan Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4.3. China
    • 10.4.3.1. Key Country Dynamics
    • 10.4.3.2. Competitive Scenario
    • 10.4.3.3. Prevalence Insights
    • 10.4.3.4. Regulatory Framework
    • 10.4.3.5. Reimbursement Structure
    • 10.4.3.6. China Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4.4. India
    • 10.4.4.1. Key Country Dynamics
    • 10.4.4.2. Competitive Scenario
    • 10.4.4.3. Prevalence Insights
    • 10.4.4.4. Regulatory Framework
    • 10.4.4.5. Reimbursement Structure
    • 10.4.4.6. India Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4.5. Australia
    • 10.4.5.1. Key Country Dynamics
    • 10.4.5.2. Competitive Scenario
    • 10.4.5.3. Prevalence Insights
    • 10.4.5.4. Regulatory Framework
    • 10.4.5.5. Reimbursement Structure
    • 10.4.5.6. Australia Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4.6. Thailand
    • 10.4.6.1. Key Country Dynamics
    • 10.4.6.2. Competitive Scenario
    • 10.4.6.3. Prevalence Insights
    • 10.4.6.4. Regulatory Framework
    • 10.4.6.5. Reimbursement Structure
    • 10.4.6.6. Thailand Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.4.7. South Korea
    • 10.4.7.1. Key Country Dynamics
    • 10.4.7.2. Competitive Scenario
    • 10.4.7.3. Prevalence Insights
    • 10.4.7.4. Regulatory Framework
    • 10.4.7.5. Reimbursement Structure
    • 10.4.7.6. South Korea Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
• 10.5. Latin America
  • 10.5.1. Latin America Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.5.2. Brazil
    • 10.5.2.1. Key Country Dynamics
    • 10.5.2.2. Competitive Scenario
    • 10.5.2.3. Prevalence Insights
    • 10.5.2.4. Regulatory Framework
    • 10.5.2.5. Reimbursement Structure
    • 10.5.2.6. Brazil Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.5.3. Mexico
    • 10.5.3.1. Key Country Dynamics
    • 10.5.3.2. Competitive Scenario
    • 10.5.3.3. Prevalence Insights
    • 10.5.3.4. Regulatory Framework
    • 10.5.3.5. Reimbursement Structure
    • 10.5.3.6. Mexico Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.5.4. Argentina
    • 10.5.4.1. Key Country Dynamics
    • 10.5.4.2. Competitive Scenario
    • 10.5.4.3. Prevalence Insights
    • 10.5.4.4. Regulatory Framework
    • 10.5.4.5. Reimbursement Structure
    • 10.5.4.6. Argentina Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
• 10.6. Middle East & Africa
  • 10.6.1. Middle East & Africa Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.6.2. South Africa
    • 10.6.2.1. Key Country Dynamics
    • 10.6.2.2. Competitive Scenario
    • 10.6.2.3. Prevalence Insights
    • 10.6.2.4. Regulatory Framework
    • 10.6.2.5. Reimbursement Structure
    • 10.6.2.6. South Africa Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.6.3. Saudi Arabia
    • 10.6.3.1. Key Country Dynamics
    • 10.6.3.2. Competitive Scenario
    • 10.6.3.3. Prevalence Insights
    • 10.6.3.4. Regulatory Framework
    • 10.6.3.5. Reimbursement Structure
    • 10.6.3.6. Saudi Arabia Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.6.4. UAE
    • 10.6.4.1. Key Country Dynamics
    • 10.6.4.2. Competitive Scenario
    • 10.6.4.3. Prevalence Insights
    • 10.6.4.4. Regulatory Framework
    • 10.6.4.5. Reimbursement Structure
    • 10.6.4.6. UAE Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)
  • 10.6.5. Kuwait
    • 10.6.5.1. Key Country Dynamics
    • 10.6.5.2. Competitive Scenario
    • 10.6.5.3. Prevalence Insights
    • 10.6.5.4. Regulatory Framework
    • 10.6.5.5. Reimbursement Structure
    • 10.6.5.6. Kuwait Dry Eye Syndrome Treatment Market Estimates And Forecasts, 2018-2030 (USD Million)

Chapter 11. Competitive Landscape

• 11.1. Company Categorization
• 11.2. Company Market Share Analysis, 2022
• 11.3. Strategy Mapping
• 11.4. Company Profiles/Listing
  • 11.4.1. NOVARTIS AG.
    • 11.4.1.1. Overview
    • 11.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.1.3. Product Benchmarking
    • 11.4.1.4. Strategic Initiatives
  • 11.4.2. ABBVIE, INC.
    • 11.4.2.1. Overview
    • 11.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.2.3. Product Benchmarking
    • 11.4.2.4. Strategic Initiatives
  • 11.4.3. SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 11.4.3.1. Overview
    • 11.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.3.3. Product Benchmarking
    • 11.4.3.4. Strategic Initiatives
  • 11.4.4. SANTEN PHARMACEUTICAL CO., LTD.
    • 11.4.4.1. Overview
    • 11.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.4.3. Product Benchmarking
    • 11.4.4.4. Strategic Initiatives
  • 11.4.5. AFT PHARMACEUTICALS
    • 11.4.5.1. Overview
    • 11.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.5.3. Product Benchmarking
    • 11.4.5.4. Strategic Initiatives
  • 11.4.6. JOHNSON & JOHNSON SERVICES, INC.
    • 11.4.6.1. Overview
    • 11.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.6.3. Product Benchmarking
    • 11.4.6.4. Strategic Initiatives
  • 11.4.7. OTSUKA PHARMACEUTICAL CO., LTD.
    • 11.4.7.1. Overview
    • 11.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.7.3. Product Benchmarking
    • 11.4.7.4. Strategic Initiatives
  • 11.4.8. OASIS MEDICAL.
    • 11.4.8.1. Overview
    • 11.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.8.3. Product Benchmarking
    • 11.4.8.4. Strategic Initiatives
  • 11.4.9. OYSTER POINT PHARMA, INC.
    • 11.4.9.1. Overview
    • 11.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.9.3. Product Benchmarking
    • 11.4.9.4. Strategic Initiatives
  • 11.4.10. BAUSCH & LOMB
    • 11.4.10.1. Overview
    • 11.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
    • 11.4.10.3. Product Benchmarking
    • 11.4.10.4. Strategic initiatives